Newsroom

In This Section

News Release

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Print Page | RSS Feeds | Email Alerts

Building On Our Heritage

More than 150 years of quality, integrity and service.

Learn More

Join Us

Invest in your own career with Mallinckrodt and let’s do something dynamic together..

Learn How